Research

Mechanisms of Disease Persistence in Gastrointestinal Stromal Tumors

By Tamas Ordog, LRG Research Team, Martin Zörnig and Yujiro Hayashi Dr. Tamas Ordog Gastrointestinal stromal tumors (GIST) represent a substantial proportion of human bone and soft tissue sarcomas.1 GIST are thought [...]

By |2019-10-31T12:01:09-04:00October 16th, 2015|News, Research|

Immunotherapy: Game Changing Cancer Treatments

Two recent articles summarize the promise that immunotherapy provides for the future of cancer treatment. Immunotherapy refers to treatments that aid your own immune system in fighting cancer cells. The first, from U.S. News [...]

By |2018-11-05T14:35:28-05:00October 15th, 2015|Drug Treatment, News, Research|

Institute of Medicine Report Findings on Diagnostic Error

A recent report from the Institute of Medicine (IOM), Improving Diagnosis in Healthcare, outlines findings on the state of diagnostic error in our healthcare system. A follow-up to the 2000 landmark study, To Err [...]

By |2019-09-24T12:54:22-04:00October 7th, 2015|Diagnosis, News, Research|

Memorial Sloan Kettering Cancer Center Announces Innovative Basket Study

Memorial Sloan Kettering Cancer Center (MSKCC) recently announced results from a "basket study," an innovative clinical trial design that studies response to drugs based on specific mutations in patients' tumors rather than where the cancer originated.The [...]

By |2018-11-02T14:54:14-04:00August 26th, 2015|Clinical Trials, News, Research|

Update on Potential Treatments for Imatinib-Resistant GIST

In a recent article entitled "Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions" published online in Springer for Research and Development,  LRG Research Team member Sebastian Bauer [...]

By |2019-10-31T12:01:30-04:00July 31st, 2015|News, Research|

New Study Reviews Follow-Up Treatment Strategies for GIST

In a recent article in the May 2015 edition of the European Journal of Cancer, Heikki Joensuu, one of the foremost authorities on adjuvant treatment for GIST, discussed how follow-up treatment is currently performed for [...]

By |2018-11-05T15:34:20-05:00June 30th, 2015|News, Research, Survival Strategies|
Go to Top